Molecular Mechanisms of Atrial Fibrillation Recurrence After Successful Catheter Ablation
Cells · 24.12.2025 · 15 (1) · 36
DOI: 10.3390/cells15010036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 24.12.2025. Verfasst von Muhammad Sanusi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Trinity Health Oakland/Wayne State University, Pontiac, MI 48341, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia globally, linked to significant cardiovascular morbidity and mortality. Catheter ablation has emerged as a primary therapeutic approach, yet substantial recurrence rates limit its long-term efficacy. This review critically examines the molecular mechanisms underlying AF recurrence post-ablation, synthesizing recent findings from current literature. Key molecular pathways identified include structural remodeling mediated by fibrosis involving transforming growth factor-beta 1 (TGF-β1) and matrix metalloproteinases (MMPs), ion-channel dysregulation, inflammatory pathways, autonomic nervous system imbalance, and genetic and epigenetic alterations. Despite considerable advances, critical gaps persist due to small, heterogeneous studies and insufficient long-term follow-up. Comprehensive mechanistic research integrating genomics, proteomics, and advanced imaging is urgently needed to better characterize these pathways. Future studies must validate biomarkers such as TGF-β1, MMPs, connexins, and novel markers like GDF-15 and relaxin. Clinical translation of these molecular insights through precision diagnostics and personalized interventions holds great promise to enhance patient selection, optimize ablation strategies, reduce recurrence, and ultimately improve clinical outcomes in AF management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Trinity Health Oakland/Wayne State University, Pontiac, MI 48341, USA.
- Department of Family Medicine, Western Michigan Homer Stryker M.D. School of Medicine, Kalamazoo, MI 49008, USA.
- Department of Cardiology, Trinity Health Oakland/Wayne State University, Pontiac, MI 48341, USA.
- Department of Cardiology, Endeavor Health Cardiovascular Institute, Glenview, IL 60026, USA.
- Electrophysiology Division, Department of Cardiology, Kansas University Medical Center, Kansas City, KS 66160, USA.
ORCID-Profile: Muhammad Sanusi, Roopeessh Vempati, Dinakaran Umashankar, Fawaz Mohammed, Maneeth Mylavarapu, Christian Toquica Gahona
Zitieren
APA
Sanusi, M., Vempati, R., Umashankar, D., Tarannum, S., Varma, Y., Mohammed, F., Mylavarapu, M., Zakaria, F., Nair, R., Reddy, Y. M., & Toquica Gahona, C. (2025). Molecular Mechanisms of Atrial Fibrillation Recurrence After Successful Catheter Ablation. Cells, 15(1), 36. https://doi.org/10.3390/cells15010036
Vancouver
Sanusi M, Vempati R, Umashankar D, Tarannum S, Varma Y, Mohammed F, et al. Molecular Mechanisms of Atrial Fibrillation Recurrence After Successful Catheter Ablation. Cells. 2025;15(1):36. doi:10.3390/cells15010036
BibTeX
@article{Sanusi2025,
author = {Sanusi, Muhammad and Vempati, Roopeessh and Umashankar, Dinakaran and Tarannum, Suha and Varma, Yash and Mohammed, Fawaz and Mylavarapu, Maneeth and Zakaria, Faiza and Nair, Rajiv and Reddy, Yeruva Madhu and Toquica Gahona, Christian},
title = {Molecular Mechanisms of Atrial Fibrillation Recurrence After Successful Catheter Ablation},
journal = {Cells},
year = {2025},
volume = {15},
number = {1},
pages = {36},
doi = {10.3390/cells15010036}
}
EUVIMED